These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 14662695)

  • 21. A case of congenital warfarin syndrome due to maternal drug administration during the pregnancy.
    Dilli D; Oğuz S; Dilmen U
    Genet Couns; 2011; 22(2):221-6. PubMed ID: 21848016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anticoagulation with prosthetic cardiac valves.
    Topol EJ;
    Arch Intern Med; 2003 Oct; 163(18):2251-2. PubMed ID: 14557227
    [No Abstract]   [Full Text] [Related]  

  • 23. ACOG Committee Opinion: safety of Lovenox in pregnancy.
    American College of Obstetricians and Gynecologists
    Obstet Gynecol; 2002 Oct; 100(4):845-6. PubMed ID: 12387283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unbalanced protein S deficiency due to warfarin treatment as a possible cause for thrombosis.
    Haran MZ; Lichman I; Berebbi A; Weinmann E; Rosenberg N
    Br J Haematol; 2007 Oct; 139(2):310-1. PubMed ID: 17897308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An audit of pregnant women with prosthetic heart valves at a tertiary hospital in South Africa: a five-year experience.
    Mazibuko B; Ramnarain H; Moodley J
    Cardiovasc J Afr; 2012 May; 23(4):216-21. PubMed ID: 22614667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two cases of warfarin embryopathy: a re-emergence of this condition?
    Wellesley D; Moore I; Heard M; Keeton B
    Br J Obstet Gynaecol; 1998 Jul; 105(7):805-6. PubMed ID: 9692425
    [No Abstract]   [Full Text] [Related]  

  • 27. Anticoagulation during pregnancy in women with prosthetic valves: evidence, guidelines and unanswered questions.
    Nishimura RA; Warnes CA
    Heart; 2015 Mar; 101(6):430-5. PubMed ID: 25573983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Warfarin or enoxaparin: the choice for the patient with venous thrombosis in the first month of treatment].
    Vorob'eva NM; Panchenko EP; Kirienko AI; Dobrovol'skiĭ AB; Titaeva EV; Ermolina OV; Balakhonova TV; Andriiashkin VV; Leont'ev SG
    Ter Arkh; 2009; 81(9):57-61. PubMed ID: 19827655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pregnancy in women with artificial heart valves].
    Krzemińska-Pakuła M; Pajszczyk-Kieszkiewicz T
    Kardiol Pol; 1992 Sep; 37(9):161-4. PubMed ID: 1479774
    [No Abstract]   [Full Text] [Related]  

  • 30. Anticoagulation protocol and early prosthetic valve thrombosis.
    Talwar S; Kapoor CK; Velayoudam D; Kumar AS
    Indian Heart J; 2004; 56(3):225-8. PubMed ID: 15584565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pregnancy in patients with prosthetic heart valves.
    Oakley C
    Br Med J (Clin Res Ed); 1983 May; 286(6379):1680-2. PubMed ID: 6405932
    [No Abstract]   [Full Text] [Related]  

  • 32. [Anticoagulant therapy in pregnant women with mechanical prosthetic heart valves. Review of international clinical guidelines].
    Adilova LR; Shifman EM; Adamian LV; Liashko ES; Tiul'kina EE
    Anesteziol Reanimatol; 2013; (6):62-6. PubMed ID: 24749270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticoagulation therapy during pregnancy of patients with artificial heart valves: fetomaternal outcome.
    Plesinac SD; Darko PV; Pilic IZ; Babovic IR
    Arch Gynecol Obstet; 2006 Jun; 274(3):141-5. PubMed ID: 16598476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Warfarin and herbal products interaction causing prosthetic aortic valve thrombosis presenting as acute myocardial infarction.
    Mendoza CE; Ferreira AC; de Marchena E
    J Heart Valve Dis; 2004 Jan; 13(1):22-4. PubMed ID: 14765834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Approaches for prescribing anticoagulant therapy to patients with prosthetic heart valves].
    Gorbunova EV
    Klin Med (Mosk); 2013; 91(2):49-52. PubMed ID: 23718066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-activated factor X profiles in pregnant women receiving antenatal thromboprophylaxis with enoxaparin.
    Brennand JE; Walker ID; Greer IA
    Acta Haematol; 1999 Mar; 101(1):53-5. PubMed ID: 10085440
    [No Abstract]   [Full Text] [Related]  

  • 37. Maternal and fetal sequelae of anticoagulation during pregnancy in patients with mechanical heart valve prostheses.
    Sareli P; England MJ; Berk MR; Marcus RH; Epstein M; Driscoll J; Meyer T; McIntyre J; van Gelderen C
    Am J Cardiol; 1989 Jun; 63(20):1462-5. PubMed ID: 2729133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ACOG committee opinion. Safety of Lovenox in pregnancy. Number 276, October 2002. Committee on Obstetric Practice.
    American College of Obsterticians and Gynecologists Committee on Obstetric Practice. Committee on Obstetric Practice
    Int J Gynaecol Obstet; 2002 Dec; 79(3):299-300. PubMed ID: 12501868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of pregnancy on the duration of bovine pericardial bioprostheses.
    James PR
    Am Heart J; 2000 May; 139(5):924-5. PubMed ID: 10783229
    [No Abstract]   [Full Text] [Related]  

  • 40. Warfarin embryopathy.
    Warkany J
    Teratology; 1976 Oct; 14(2):205-9. PubMed ID: 790626
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.